亚洲欧美日韩牲夜夜综合久久-四虎永久精品在线播放-亚洲一区二区天堂在线-亚洲精品久久久久久成人爱看av

咨詢熱線

15000266580

當前位置:首頁  >  技術文章  >  日本批準利用干細胞療法治療眼部疾病

日本批準利用干細胞療法治療眼部疾病

更新時間:2013-07-26      點擊次數(shù):3091

   日本研究人員獲得批準,可以開展利用干細胞療法治療老年性黃斑變性(age-related macular degeneration,AMD),一種引起老年人視力下降的主要疾病。日本的研究人員誘導AMD患者身上取下的皮膚細胞使其處于一種類似于干細胞的狀態(tài)后再將其轉至患者,以達到治療效果。

干細胞具有廣泛的性,具有廣泛的醫(yī)療前景。去年,Kyoto University的Shinya Yamanaka即憑借干細胞領域的研究獲得諾貝爾獎。

詳細英文報道:

Japanese researchers have won permission to embark on a pioneering clinical study of a stem cell therapy for age-related macular degeneration, a major cause of vision loss in aging patients. The planned trial is being hailed as the first human test of a stem cell therapy made from patients' own cells.

Japan provides an appropriate proving ground for induced pluripotent stem (iPS) cell therapies. Last year professor Shinya Yamanaka of Kyoto University won a piece of a Nobel Prize for his work on converting adult cells into stem cells. The stem cells have broad potential in medicine because they can evolve into a variety to cell types with the potential to repair diseased or damaged organs, and they skirt the political quagmire of harvesting stem cells from human embryos.

As AFP reported, researchers in the Japanese study plan to take skin cells from AMD patients, coax the cells into a stem-like state, and then reintroduce them to the patients. The study calls for testing the therapeutic approach in 6 patients, with the trial set to begin next year in Kobe. Applications to conduct the trial came from the Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation.

Stem cells offer a whole new way to treat vision problems. Today, AMD patients take injected therapies such as Eylea and Lucentis to combat the disease by inhibiting VEGF to stymie the formation of leaky blood vessels, which lead to deterioration of the eye tissue that is key to central vision.

However, with pioneering clinical trials comes great risk. As professor Chris Mason of University College London noted to the BBC, researchers lack evidence on the safety of iPS cells in humans. The hope is that using patients' own cells to generate the therapies could reduce the risk of their bodies rejecting the stem cells.

 

聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2024 上海復祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
技術支持:化工儀器網(wǎng)    管理登陸
少妇高潮视频在线观看| 午夜福利中文字幕在线亚洲| 色婷婷狠狠久久综合中文一本 | 在线日韩观看免费av| 女人被爽到高潮呻吟免费看| 日韩人妻一区二区三区蜜桃视频密| 精品亚洲韩国一区二区三区| 欧美私人影院—区二区日本| 国产一级三级视频在线| 一级欧美黄片在线播放| 亚洲黄色片一区二区三区| 国产自拍最新在线视频| 一本在线不卡中文字幕| 18禁黄久久久一区二区三区| 亚洲人妖视频在线观看| 日日狠狠久久偷偷综合色| 久久精品国产亚洲av清纯| 91精品国产高清91久久久久久| 男人天堂av一区二区| 欧美国产日韩在线播放| 国产av麻豆全部免费| 在线观看免费完整观看一区二区| 麻豆视频在线观看传媒| 日本一区二区三区电影播放| 一欧美一区二区三区| 日本午夜精品在线观看| 自偷自拍在线免费观看| 暖暖免费中文高清日本三区| 十八禁一区二区在线观看| 亚洲人成网站18禁止人| 日本免费一区二区三区的电影啊| 精品国产av色一区二区| 日韩高清av一区二区| 在线观看午夜视频免费| 亚洲日本国产精品第一页| 大龄熟妇丰满有水多毛浓| 亚洲毛片一区二区在线| 风韵丰满熟妇老熟女啪啪| 亚洲图文一区二区三区四区| 青青草日韩欧美在线观看| 性生活的视频免费观看麻豆|